Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY) Q2 2025 Earnings Call Transcript July 31, 2025
Alnylam Pharmaceuticals, Inc. beats earnings expectations. Reported EPS is $0.32, expectations were $-0.54371.
Operator: Good morning, ladies and gentlemen, and welcome to the Alnylam Q2 2025 Earnings Conference Call. [Operator Instructions] This call is being recorded on Thursday, July 31, 2025. I would now like to turn the conference over to the company. Please go ahead.
Christine Regan Akinc: Good...
